The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Start Date
5/1/2026
Completion Date
12/31/2028
Summary
The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are: * Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better? Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.
Detailed Description
This study will assess the acceptability, feasibility, and proof-of-concept for MedMemos, a novel medication adherence promotion intervention developed for caregivers of children who received a pediatric hematopoietic stem cell transplant (PAHCT).
Eligibility Criteria
Age Range: No minimum to 12 years
Interventions
MedMemos
Conditions
Locations
Nationwide Children's Hospital
Columbus, Ohio 43205
United States